-
Light at the End of the Tunnel for ASPS PatientsImmunotherapy has helped some young people with alveolar soft part sarcoma (ASPS), a rare cancer, but there’s more work to be done.
by Kyle Bagenstose
-
CAR T-cell Therapy: Understanding the Warning and the RisksThe FDA requires a warning with CAR T-cell therapies about an increased risk of cancer from the treatment. Should you be concerned?
by Sandra Gordon
-
Overcoming Lung Cancer Stigma With UnderstandingShirley Muñoz wants to use her experience as a younger lung cancer patient to break down barriers to care for her community through translation and advocacy.
by Cameron Walker
-
Real-world Outcomes in Multiple MyelomaStudy shines a light on the differences in outcomes between clinical trial patients with multiple myeloma and those receiving cancer treatment in their community.
by Sandra Gordon
-
Some Breast Cancer Patients May Safely Skip RadiationThree presentations at SABCS in December find that it may be safe in certain cases for people with breast cancer to go without radiation.
by Cancer Research Catalyst
-
Emerging Treatments for Brain Metastases in Breast CancerSABCS panel describes advances and pivotal questions in managing patients whose breast cancer has metastasized to their brain.
by Marci A. Landsmann
-
Forward Look
CDK4/6 Inhibitors in Early-stage Breast CancerA mainstay of treatment for metastatic breast cancer, CDK4/6 inhibitors are moving into early-stage treatment.
by Darcy Lewis
-
Forward Look
A Less Radical ApproachSome women with early-stage cervical cancer may be able to receive simple hysterectomy, which reduces the risk of complications.
by Thomas Celona
-
Forward Look
Ultrasound Device Opens Blood-brain BarrierAn implantable device, along with an infusion of microbubbles, helps increase chemotherapy concentrations for brain cancer.
by Eric Fitzsimmons
-
Forward Look
The Lasting Benefit of Immune Checkpoint InhibitorsStudy suggests people with advanced lung cancer who have a sustained response to immunotherapy can safely stop treatment after two years.
by Lindsay Modglin
Reports on breast density inform women of their status but raise questions about what to do next.
by Robin Roenker
Injection Immunotherapies Get FDA ApprovalGiving immunotherapy drugs as injections, rather than intravenously, means patients can spend less time in the hospital or treatment center.
by Laura Gesualdi-Gilmore
Designing Clinical Trials for the PatientChallenges in developing and studying treatments call for new ways of thinking about cancer research.
by Eric Fitzsimmons
Treating Smoldering Multiple MyelomaA monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
